Nevertheless, it is likely that the development of B cells that encode a BCR specific for a tumor antigen might be a better alternative to the above strategies, since the target antigen would be processed more rapidly by the BCR machinery, as compared to classical antigen internalization by pinocytosis, for instance. The gene discussed is BCR; the disease is neoplasm.